亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

濟南偉都化工有限公司  

醫(yī)藥原料藥和醫(yī)藥中間體

搜索
新聞中心
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:姚銳
  • 電話:0531-88873471
  • 郵件:wedochem@gmail.com
  • 傳真:0531-88873470
  • QQ:1783747865
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產(chǎn)品 > 112626-50-3
112626-50-3
單價 面議對比
詢價 暫無
發(fā)貨 山東濟南市付款后3天內(nèi)
品牌 偉都化工
型號 112626-50-3
規(guī)格 99%
過期 長期有效
更新 2013-11-25 11:41
 
詳細信息

3-氮雜雙環(huán)[3.3.0]辛烷鹽酸鹽 格列奇特中間體 112626-50-3

中文別名: 3-雜氮二環(huán)[3.3.0]辛烷 鹽酸鹽; 3-氮雜雙環(huán)[3,3,0]辛烷HCL

英文名稱:3-AZABICYCLO[3.3.0]OCTANE HYDROCHLORIDE

英文別名: 3-AZABICYCLO[3,3,0]OCTANE HCL; 3-AZABICYCLO[3.3.0]OCTANE HYDROCHLORIDE,98%; octahydrocyclopenta[c]pyrrole hydrochloride

CAS號:112626-50-3

分子式:C7H14ClN

分子量:147.6458

用途:合成格列齊特

©2025 濟南偉都化工有限公司 版權(quán)所有   技術支持:化工網(wǎng)   訪問量:22725  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |